Lead Product(s): GLPG1690
Therapeutic Area: Dermatology
Highest Development Status: Phase II Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 29, 2020
With the NOVESA Phase 2 trial in SSc fully recruited, the company expects to see topline data in the second half of the year.